BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10960076)

  • 1. ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets.
    Mahaut-Smith MP; Ennion SJ; Rolf MG; Evans RJ
    Br J Pharmacol; 2000 Sep; 131(1):108-14. PubMed ID: 10960076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors.
    Vial C; Rolf MG; Mahaut-Smith MP; Evans RJ
    Br J Pharmacol; 2002 Jan; 135(2):363-72. PubMed ID: 11815371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
    Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG
    J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
    Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
    Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.
    Gerevich Z; Zadori Z; Müller C; Wirkner K; Schröder W; Rubini P; Illes P
    Br J Pharmacol; 2007 May; 151(2):226-36. PubMed ID: 17351651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery.
    Malmsjö M; Adner M; Harden TK; Pendergast W; Edvinsson L; Erlinge D
    Br J Pharmacol; 2000 Sep; 131(1):51-6. PubMed ID: 10960068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
    Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling.
    Tolhurst G; Vial C; Léon C; Gachet C; Evans RJ; Mahaut-Smith MP
    Blood; 2005 Sep; 106(5):1644-51. PubMed ID: 15914557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of a P2T ADP receptor in Xenopus oocytes injected with megakaryocyte (CMK 11-5) RNA.
    Greco NJ
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):769-77. PubMed ID: 9108793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
    Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
    Fumagalli M; Brambilla R; D'Ambrosi N; Volonté C; Matteoli M; Verderio C; Abbracchio MP
    Glia; 2003 Sep; 43(3):218-03. PubMed ID: 12898701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle.
    McMurray G; Dass N; Brading AF
    Br J Pharmacol; 1998 Apr; 123(8):1579-86. PubMed ID: 9605564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney.
    Vonend O; Stegbauer J; Sojka J; Habbel S; Quack I; Robaye B; Boeynaems JM; Rump LC
    Br J Pharmacol; 2005 May; 145(1):66-74. PubMed ID: 15711586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
    Reifel Saltzberg JM; Garvey KA; Keirstead SA
    Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development.
    Agresti C; Meomartini ME; Amadio S; Ambrosini E; Serafini B; Franchini L; Volonté C; Aloisi F; Visentin S
    Glia; 2005 Apr; 50(2):132-44. PubMed ID: 15657938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
    Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
    Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets.
    MacKenzie AB; Mahaut-Smith MP; Sage SO
    J Biol Chem; 1996 Feb; 271(6):2879-81. PubMed ID: 8621673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.